Cargando…
Fibroblasts and Alectinib switch the evolutionary games played by non-small cell lung cancer
Heterogeneity in strategies for survival and proliferation among the cells which constitute a tumour is a driving force behind the evolution of resistance to cancer therapy. The rules mapping the tumour’s strategy distribution to the fitness of individual strategies can be represented as an evolutio...
Autores principales: | Kaznatcheev, Artem, Peacock, Jeffrey, Basanta, David, Marusyk, Andriy, Scott, Jacob G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6467526/ https://www.ncbi.nlm.nih.gov/pubmed/30778184 http://dx.doi.org/10.1038/s41559-018-0768-z |
Ejemplares similares
-
The Contribution of Evolutionary Game Theory to Understanding and Treating Cancer
por: Wölfl, Benjamin, et al.
Publicado: (2021) -
Cancer treatment scheduling and dynamic heterogeneity in social dilemmas of tumour acidity and vasculature
por: Kaznatcheev, Artem, et al.
Publicado: (2017) -
Collateral sensitivity networks reveal evolutionary instability and novel treatment strategies in ALK mutated non-small cell lung cancer
por: Dhawan, Andrew, et al.
Publicado: (2017) -
Selection-driven tumor evolution with public goods leads to patterns of clonal expansion consistent with neutral growth
por: Edwards, Jack, et al.
Publicado: (2020) -
Outcomes of switching from crizotinib to alectinib in patients with advanced non-small cell lung cancer with anaplastic lymphoma kinase fusion
por: Pan, Yingying, et al.
Publicado: (2021)